An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthalmic Solution and Xalatan in Patients With Glaucoma or Ocular Hypertension

Authors

Keywords

Journal

Volume 22, Issue 9, Pages 707-712

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2012-05-18

DOI

10.1097/ijg.0b013e318259b47c

References

View 1 related references

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now